McGill University Health Centre-Vaccine Study Centre

Pierrefonds, Quebec H9H 4Y6

0 studies enrolling now · 4 studies all time

What they study most

Cytomegalovirus Infection, Healthy, Pneumococcal Disease, SARS-CoV-2 Infection

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants — Completed
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults — Running, not enrolling
• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. — Completed